Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Midazolam vs Dexmedetomidine for Sedation in Mandible Fracture Surgery
NCT07502651Phase 1Enrolling by invitation
- Sponsor
- Postgraduate Institute of Dental Sciences
- Start
- May 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dexmedetomidine in sedation (2 arms), sponsored by Postgraduate Institute of Dental Sciences. Primary endpoints: Observer Assessment of Alertness/Sedation Scale and Comparison of the efficacy of intranasal midazolam and dexmedetomidine at 18 months. Started May 2025; status: enrolling by invitation.
02
Drugs
dexmedetomidine
03
Conditions
sedation
Beyond the preview
Go deeper on NCT07502651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07502651.